Vicarious Surgical annual stock-based compensation
2020
2021
2022
2023
2024
2025
Vicarious Surgical Stock-Based Compensation Growth & History (RBOT)
Vicarious Surgical's stock-based compensation was $8.1M for fiscal 2025.
View full Vicarious Surgical company overviewVicarious Surgical annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $8.1M | −$3.8M | −31.66% |
| 2024 | 2024-12-31 | $11.9M | −$1.4M | −10.27% |
| 2023 | 2023-12-31 | $13.3M | $1.0M | +8.26% |
| 2022 | 2022-12-31 | $12.3M | $8.6M | +231.75% |
| 2021 | 2021-12-31 | $3.7M | $3.2M | +724.55% |
| 2020 | 2020-12-31 | $448,000 | — | — |
Vicarious Surgical quarterly stock-based compensation
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q1 2026 | 2026-03-31 | $1.1M | −$1.7M | −61.82% |
| Q4 2025 | 2025-12-31 | $1.1M | −$1.7M | −60.75% |
| Q3 2025 | 2025-09-30 | $2.0M | −$888,000 | −30.23% |
| Q2 2025 | 2025-06-30 | $2.2M | −$870,000 | −28.38% |
| Q1 2025 | 2025-03-31 | $2.8M | −$304,000 | −9.84% |
| Q4 2024 | 2024-12-31 | $2.8M | −$265,000 | −8.62% |
| Q3 2024 | 2024-09-30 | $2.9M | −$677,000 | −18.73% |
| Q2 2024 | 2024-06-30 | $3.1M | −$258,000 | −7.76% |
| Q1 2024 | 2024-03-31 | $3.1M | −$163,000 | −5.01% |
| Q4 2023 | 2023-12-31 | $3.1M | −$474,000 | −13.36% |
| Q3 2023 | 2023-09-30 | $3.6M | −$35,000 | −0.96% |
| Q2 2023 | 2023-06-30 | $3.3M | $544,000 | +19.57% |
| Q1 2023 | 2023-03-31 | $3.3M | $977,000 | +42.91% |
| Q4 2022 | 2022-12-31 | $3.5M | $847,000 | +31.35% |
| Q3 2022 | 2022-09-30 | $3.6M | $3.3M | +894.28% |
| Q2 2022 | 2022-06-30 | $2.8M | $2.4M | +653.39% |
| Q1 2022 | 2022-03-31 | $2.3M | $2.0M | +789.45% |
| Q4 2021 | 2021-12-31 | $2.7M | — | — |
| Q3 2021 | 2021-09-30 | $367,000 | — | — |
| Q2 2021 | 2021-06-30 | $369,000 | — | — |
| Q1 2021 | 2021-03-31 | $256,000 | — | — |
Vicarious Surgical stock-based compensation trends
Over the last five fiscal years, Vicarious Surgical's stock-based compensation increased from $448,000 to $8.1M, a change of $7.7M. The latest reported quarter, Q1 2026, shows $1.1M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Vicarious Surgical source filings ↗